A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
Hepatoblastoma is the most common childhood liver cancer. Although survival has improved significantly over the past few decades, there remains a group of children with aggressive disease who do not respond to current treatment regimens. There is a critical need for novel models to study aggressive...
Main Authors: | James A. Saltsman, William J. Hammond, Nicole J. C. Narayan, David Requena, Helmuth Gehart, Gadi Lalazar, Michael P. LaQuaglia, Hans Clevers, Sanford Simon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2668 |
Similar Items
-
Chloroquine Triggers Cell Death and Inhibits PARPs in Cell Models of Aggressive Hepatoblastoma
by: Katja Eloranta, et al.
Published: (2020-07-01) -
Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01) -
Teratoid Hepatoblastoma—Our Experience
by: Lara Berklite, et al.
Published: (2022-12-01) -
SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration
by: Katja Eloranta, et al.
Published: (2023-01-01) -
Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
by: Katherine M. Somers, et al.
Published: (2023-08-01)